Single Test Detects Multiple Respiratory Infections Including COVID-19 and Flu to Inform Treatment Options. Get results in 1-2 days!
LabCorp a leading global life sciences company that is deeply integrated in guiding patient care, today announced the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus (RSV). The single-panel test, which detects multiple types of infections, can help doctors diagnose patients and make decisions about treatment options. The test is available to patients through doctors, hospitals, and other authorized healthcare providers nationwide. LabCorp has also submitted an application to the U.S. Food and Drug Administration (FDA) to offer the combined test through an at-home test collection kit, which is offered added convenience and accessibility.
Individuals infected with COVID-19, influenza A / B, or RSV, often experience similar symptoms of cough, fever, chest tightness, and body aches, providing a potential surge of patients seeking testing. Leveraging the scientific and technological expertise to simultaneously test for four major respiratory viruses, including COVID-19, will provide individuals a simple, efficient way to diagnose respiratory infection.
The Centers for Disease Control and Prevention estimated that there were 39 to 56 million flu illnesses, resulting in 18 to 26 million medical visits. The significant flu and RSV season this year could put an added strain on the healthcare system, as people experience similar symptoms – fever, cough, and aches, for example – with COVID-19 and respiratory viruses.
The at-home test will be another convenient option for individuals to determine if they have the flu, COVID-19, or RSV. Thousands of people have used the company’s COVID-19 Pixel by LabCorp at-home test kit, with 95 percent of users being very satisfied or satisfied with their experience. The at-home test uses a short swab that is easily inserted into the individual’s lower nostril, reducing the discomfort associated with much longer swabs.
- Order your test online
- Easy at-home test kit with a nasal swab
- Email notification once test results are available
Your sample will be sent to Labcorp’s high complexity CLIA-certified lab partner for full analysis by our team of clinical scientists.
These molecular diagnostic tests can confirm the presence of COVID-19, Flu, and RSV in time for flu season. Results are typically available within 24-48 hours after arriving at the lab. This test will not indicate immunity or detect antibodies.